Aside from the use of saliva, researchers are also looking into the use of blood and cerebrospinal fluid for testing of this neurodegenerative disorder.
Past News ReleasesRSS
Toronto, ON (PRWEB) February 09, 2013
Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on a new study that explains how a new saliva test is making breakthroughs in Parkinson’s disease.
As Bel Marra Health reports in its article (http://www.belmarrahealth.com/brain-function/the-breakthrough-saliva-test-for-parkinsons-disease/) Parkinson’s disease is a neurodegenerative disorder that affects elderly adults and is characterized by the occurrence of tremors, slow mobility, and a peculiar walk, in which the back is usually arched and the head positioned forward.
As the Bel Marra Health article reads, according to a recent medical report published in the journal Translational Neurodegeneration, a saliva test may be helpful in detecting Parkinson’s disease based on the presence of a protein called a-synuclein, which is produced by the brain and controls motor functions. The report explained that the amount of this protein is generally lower among Parkinson’s patients compared to healthy adults.
The saliva test shows great promise in the medical field because this procedure is less invasive compared to the collection of cerebrospinal fluid for protein detection. In addition, the saliva test is relatively easy to perform because patients diagnosed with this neurodegenerative disorder often excessively produce excessive amounts of saliva, resulting in drooling in most patients.
Current treatment schemes for the symptoms of Parkinson’s include the administration of dopamine to replenish its low levels in the body. However, it is important to understand that although the use of dopamine may be initially effective, the continuous degeneration of nerve cells in the brain still continues, possibly surpassing the amount of supplemental dopamine taken on a daily basis. It is possible that dopamine treatment may eventually be ineffective in a patient with Parkinson’s disease, especially when this person progresses to a more severe stage of the disorder. Severe symptoms of Parkinson’s include involuntary twisting of the limbs and back, often disabling a person from performing routine tasks.
The recent report also discussed that the effectiveness of the saliva test in testing for this neurodegenerative disorder is based on the fact that the salivary glands of a patient are stimulated to produce excessive amounts of saliva. This feature may be due to the erratic functioning of the nerves that stimulate the salivary glands. Other diagnostic tests are also being reviewed for their effectiveness in clinical diagnostics.
Spokesperson for Bel Marra Health Dr. Victor Marchione says, “Aside from the use of saliva, researchers are also looking into the use of blood and cerebrospinal fluid for testing of this neurodegenerative disorder. If the results of these studies prove that these new tests are reliable and safe, then these might eventually be simultaneously used with neuroimaging tests such as computerized tomography (CT) and x-rays.”
(SOURCE: “j Neurology.” The spectrum of non-motor symptoms in early Parkinson disease. Jan 15, 2013)
Bel Marra Health is the maker of “Smart Pill” a high-quality nutritional supplement designed for liver health in formulations designed to address this specific health concern. All ingredients are backed with scientific evidence. Every product is tested for safety, quality, and purity at every stage of the manufacturing process. Furthermore, Bel Marra Health products are produced only in Health Canada approved facilities, going that extra mile to ensure our health conscious customers are getting top quality products. For more information on Bel Marra Health visit http://www.belmarrahealth.com or call 1-866-531-0466.